id,group_id,source,exact,prefix,suffix,anno_type,position_type,start,end,tags,all,origin_tags,comment,user,title,created
yp_ZVMjCEemymYuGIlVULg,b53nbDmi,https://europepmc.org/articles/PMC5502978/,aggrecan,"on, Australia, 1:300 dilution), "," (969D4D11, Life Technologies 1:",TextQuoteSelector,TextPositionSelector,28964,28972,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:04:15.725548+00:00
yYENFMjBEemDpEucjizCKQ,b53nbDmi,https://europepmc.org/articles/PMC5502978/,goat,y antibodies were diluted in 2% , serum in PBS (Jackson ImmunoRes,TextQuoteSelector,TextPositionSelector,28537,28541,CRT_OG,yes,[CRT_OG][ALL],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T11:57:04.353066+00:00
wx7cesjCEemodUOVik-5sg,b53nbDmi,https://europepmc.org/articles/PMC5502978/,collagen X,6% [2]. The ZCC is also rich in ,", which is absent from hyaline c",TextQuoteSelector,TextPositionSelector,10995,11005,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:04:03.219251+00:00
wpSX8MjBEemLoDNVJkPw8g,b53nbDmi,https://europepmc.org/articles/PMC5502978/,TGF-β3, transforming growth factor-β3 (,"; GroPep, Adelaide, Australia). ",TextQuoteSelector,TextPositionSelector,24422,24428,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T11:56:52.816784+00:00
vF-yusjCEemRGatAJHzBqA,b53nbDmi,https://europepmc.org/articles/PMC5502978/,collagen I ,"in, as previously described for ",methacrylamide [20]. The area ob,TextQuoteSelector,TextPositionSelector,16286,16297,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:03:51.781781+00:00
vBUF_sjBEembJgs4rW8b6A,b53nbDmi,https://europepmc.org/articles/PMC5502978/,mouse, dilution) or isotype controls (," IgG, Jackson, 1:1000) were used",TextQuoteSelector,TextPositionSelector,29039,29044,CRT_OG,yes,[CRT_OG][ALL],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T11:56:41.760250+00:00
tS4B5sjBEemdghNuKLpbIA,b53nbDmi,https://europepmc.org/articles/PMC5502978/,ACAN,"ure for RPL13A, COL1A1, COL2A1, "," and COL10A1 [9,24] or designed ",TextQuoteSelector,TextPositionSelector,27548,27552,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T11:56:30.173570+00:00
sXNdIMjCEemo_BM3hK7E0g,b53nbDmi,https://europepmc.org/articles/PMC5502978/,CD44,AMA was caused by activation of ,", as in low concentrations hyalu",TextQuoteSelector,TextPositionSelector,50874,50878,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:03:33.472192+00:00
rTmOOMjBEembpfOB_6liyw,b53nbDmi,https://europepmc.org/articles/PMC5502978/,COL2A1," literature for RPL13A, COL1A1, ",", ACAN and COL10A1 [9,24] or des",TextQuoteSelector,TextPositionSelector,27540,27546,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T11:56:17.008523+00:00
qAeoCsjBEemDo0u11k2dmg,b53nbDmi,https://europepmc.org/articles/PMC5502978/,COL1A1,"from the literature for RPL13A, ",", COL2A1, ACAN and COL10A1 [9,24",TextQuoteSelector,TextPositionSelector,27532,27538,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T11:56:08.192154+00:00
q5Tw2sjCEem3Gx-So-DpmA,b53nbDmi,https://europepmc.org/articles/PMC5502978/,mimicry,"e cartilage tissue, however the ", of native values may be not req,TextQuoteSelector,TextPositionSelector,48039,48046,WT_DS,no,[WT_DS],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:03:23.619024+00:00
pY2fUsjCEemZG6s9Iy7VTg,b53nbDmi,https://europepmc.org/articles/PMC5502978/,COL1A2, stimulate transcription of the , gene [46]. Hence the level to w,TextQuoteSelector,TextPositionSelector,45428,45434,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:03:13.622281+00:00
nIekTsjBEemnKRdcJf2UMg,b53nbDmi,https://europepmc.org/articles/PMC5502978/,ECM,ess as well as stiffness due to , deposition throughout culture. ,TextQuoteSelector,TextPositionSelector,33349,33352,WT_GP,yes,[WT_GP][ALL],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T11:55:48.850616+00:00
mYHCpsjCEemd8TOhvAu43g,b53nbDmi,https://europepmc.org/articles/PMC5502978/,skin lesions,cts are largely demonstrated on , postoperatively and hence in fi,TextQuoteSelector,TextPositionSelector,45201,45213,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:02:53.293219+00:00
lgLP6sjBEemFdEcSZjQtcQ,b53nbDmi,https://europepmc.org/articles/PMC5502978/,COL10A1,"PL13A, COL1A1, COL2A1, ACAN and "," [9,24] or designed using Primer",TextQuoteSelector,TextPositionSelector,27557,27564,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T11:55:37.955381+00:00
hXGNLsjBEemDrk80ElSpbA,b53nbDmi,https://europepmc.org/articles/PMC5502978/,HAP,"drogenic outcome, the effect of ", was limited. We overall demonst,TextQuoteSelector,TextPositionSelector,9509,9512,WT_GP,yes,[WT_GP][ALL],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T11:55:10.267952+00:00
hWzTRsjCEemymJP9tduIKQ,b53nbDmi,https://europepmc.org/articles/PMC5502978/,hypoxia,most desired matrix in terms of ,", high fluid content, ease of di",TextQuoteSelector,TextPositionSelector,40489,40496,WT_DS,no,[WT_DS],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:02:19.651943+00:00
fk-VSsvcEem0fW8HjQevfA,b53nbDmi,https://europepmc.org/articles/PMC5502978/,hypertrophy we observed (as evidenced by COL10A1,"tingly, the limited chondrocyte ", expression and immunofluorescen,TextQuoteSelector,TextPositionSelector,42201,42249,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-31T10:45:48.044537+00:00
fhOs0sjCEemXMf-6pOztxw,b53nbDmi,https://europepmc.org/articles/PMC5502978/,Modulus,lMA-ALG and GelMA/HAMA-ALG/HAP. , of cell-free constructs did not,TextQuoteSelector,TextPositionSelector,33669,33676,WT_OG,no,[WT_OG],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:02:07.330054+00:00
eCd3BMjCEembKpOSj0akYQ,b53nbDmi,https://europepmc.org/articles/PMC5502978/,donkey,", sections were incubated in 2% ", serum/PBS with IgG1-specific Al,TextQuoteSelector,TextPositionSelector,29122,29128,CRT_OG,no,CRT_OG,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:01:57.262077+00:00
dg0OYsvcEem5qetCe1w3IA,b53nbDmi,https://europepmc.org/articles/PMC5502978/,COL10A1 serving as indicators for fibrocartilage development and chondrocyte hypertrophy,"chondrogenesis, with COL1A1 and ",/calcification. Gene expression ,TextQuoteSelector,TextPositionSelector,37385,37473,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-31T10:45:34.326919+00:00
cUDJNsjCEemXMAdpPZrbQQ,b53nbDmi,https://europepmc.org/articles/PMC5502978/,hyaluronidase, by antigen retrieval with 0.1% ," (Sigma) for 30 min, which was o",TextQuoteSelector,TextPositionSelector,28395,28408,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:01:45.805283+00:00
aTJdzMjCEempzNOYw9kKDw,b53nbDmi,https://europepmc.org/articles/PMC5502978/,polymerase ,ntitative reverse transcriptase ,chain reactions (PCR) were perfo,TextQuoteSelector,TextPositionSelector,27736,27747,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:01:32.268526+00:00
Y-Y9osjCEembKVc-ryt17g,b53nbDmi,https://europepmc.org/articles/PMC5502978/,reverse transcriptase,CATATT). Real-time quantitative , polymerase chain reactions (PCR,TextQuoteSelector,TextPositionSelector,27714,27735,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:01:23.377466+00:00
W4zOeMjCEem-mFNqSnZDEw,b53nbDmi,https://europepmc.org/articles/PMC5502978/,RNase,med prior to cDNA synthesis and , digestion was performed after.P,TextQuoteSelector,TextPositionSelector,27426,27431,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:01:09.360100+00:00
VhP-2sjCEemuGYtrRNCMAg,b53nbDmi,https://europepmc.org/articles/PMC5502978/,DNase,esize complementary DNA (cDNA). , digestion was performed prior t,TextQuoteSelector,TextPositionSelector,27368,27373,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:00:59.964787+00:00
U-6kQsjDEemRHHvhwGQAng,b53nbDmi,https://europepmc.org/articles/PMC5502978/,(TGF)-β3,ning transforming growth factor ,. It has been shown that TGF-β3 ,TextQuoteSelector,TextPositionSelector,44761,44769,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:08:05.917747+00:00
Tj1A4MjCEemdhIc8wMwl2Q,b53nbDmi,https://europepmc.org/articles/PMC5502978/,proteinase K,r’s instructions.GAG content of ,-digested hydrogel and culture m,TextQuoteSelector,TextPositionSelector,26466,26478,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:00:47.040274+00:00
TPHvMsjDEemoOkNxpDUC5g,b53nbDmi,https://europepmc.org/articles/PMC5502978/,COL10A1,(B): COL2A1; (C): ACAN and (D): , on day 28 of cell culture shown,TextQuoteSelector,TextPositionSelector,38028,38035,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:07:54.439218+00:00
SkJeqMjCEem2RqO-wRtx7g,b53nbDmi,https://europepmc.org/articles/PMC5502978/,Proteinase K,dle and digested in 0.5 mg·mL−1 ," solution, on a shaker plate ove",TextQuoteSelector,TextPositionSelector,26210,26222,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:00:40.471385+00:00
RuX4NsjDEemErleDXNZsGg,b53nbDmi,https://europepmc.org/articles/PMC5502978/,ACAN , (A): COL1A1; (B): COL2A1; (C): ,and (D): COL10A1 on day 28 of ce,TextQuoteSelector,TextPositionSelector,38014,38019,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:07:44.269365+00:00
Qq7mwMjCEemr4RMnSZJZyQ,b53nbDmi,https://europepmc.org/articles/PMC5502978/, albumin,"gies), 1.25 mg·mL−1 bovine serum"," (BSA), 0.4 mM l-proline, 0.1 mM",TextQuoteSelector,TextPositionSelector,24287,24295,WS_GP,no,WS_GP,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:00:27.652677+00:00
QLgJaMjDEemHl686gGN6Wg,b53nbDmi,https://europepmc.org/articles/PMC5502978/,COL2A1,analyzed were (A): COL1A1; (B): ,; (C): ACAN and (D): COL10A1 on ,TextQuoteSelector,TextPositionSelector,38001,38007,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:07:33.937694+00:00
PXjU7sjDEemdtudpkol1kA,b53nbDmi,https://europepmc.org/articles/PMC5502978/,COL1A1,es that were analyzed were (A): ,; (B): COL2A1; (C): ACAN and (D),TextQuoteSelector,TextPositionSelector,37988,37994,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:07:28.389828+00:00
OjEScMjCEemRGFu7Z06kFA,b53nbDmi,https://europepmc.org/articles/PMC5502978/,Gro,"ing a BioScaffolder 2.1 (GeSiM, ","ßerkmannsdorf, Germany) into a 4",TextQuoteSelector,TextPositionSelector,20305,20308,WT_GP,no,[WT_GP],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:00:13.339299+00:00
NOKZyMjDEemZHf99O2awrw,b53nbDmi,https://europepmc.org/articles/PMC5502978/,IgG2a,-mouse secondary antibodies and ,-specific AlexaFluor®594-labelle,TextQuoteSelector,TextPositionSelector,29223,29228,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:07:14.038482+00:00
LT2zYMjDEemodwdPDvSE-w,b53nbDmi,https://europepmc.org/articles/PMC5502978/,IgG1,ted in 2% donkey serum/PBS with ,-specific AlexaFluor®488-labelle,TextQuoteSelector,TextPositionSelector,29144,29148,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:07:01.234658+00:00
JbboAMjDEemigiduED9Y7w,b53nbDmi,https://europepmc.org/articles/PMC5502978/,housekeeping genes,ed to the geometric mean of the , RPL13A and TBP using the compar,TextQuoteSelector,TextPositionSelector,28053,28071,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:06:48.642333+00:00
HpNwUsjDEemo_Ycx42K2yw,b53nbDmi,https://europepmc.org/articles/PMC5502978/,BSA,5 mg·mL−1 bovine serum albumin (,"), 0.4 mM l-proline, 0.1 mM asco",TextQuoteSelector,TextPositionSelector,24297,24300,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:06:36.638160+00:00
GGIWKsjDEemdtIvMB1vGlA,b53nbDmi,https://europepmc.org/articles/PMC5502978/,MMP,sired matrix metalloproteinase (,)-sensitive degradation sites an,TextQuoteSelector,TextPositionSelector,12491,12494,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:06:26.117209+00:00
EuARZsjDEemkAxOq4YPeBA,b53nbDmi,https://europepmc.org/articles/PMC5502978/,matrix metalloproteinase," bone and skin, retains desired ", (MMP)-sensitive degradation sit,TextQuoteSelector,TextPositionSelector,12465,12489,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:06:16.902936+00:00
DXtrlMjDEembKx8JWQAaEQ,b53nbDmi,https://europepmc.org/articles/PMC5502978/,collagen type X,"City, IA, USA, 1:200 dilution), "," (14-9771-82 Clone X53, Jomar Bi",TextQuoteSelector,TextPositionSelector,28858,28873,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:06:07.893212+00:00
CrkT-MjCEemAtTeGGXNznA,b53nbDmi,https://europepmc.org/articles/PMC5502978/,TBP,"-BLAST (NCBI, Bethesda, MD) for "," (5′→3′ F:AGCCAAGAGTGAAGAACAGTC,",TextQuoteSelector,TextPositionSelector,27628,27631,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T11:58:53.855820+00:00
Bf5pAsjDEemNjxOL32-7cA,b53nbDmi,https://europepmc.org/articles/PMC5502978/,collagen type II,nant collagen type (>90%) being , [1]. The zones of cartilage var,TextQuoteSelector,TextPositionSelector,10159,10175,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:05:55.450902+00:00
BJHmlMjCEemnKi-SNRIMkA,b53nbDmi,https://europepmc.org/articles/PMC5502978/,RPL13A,btained from the literature for ,", COL1A1, COL2A1, ACAN and COL10",TextQuoteSelector,TextPositionSelector,27524,27530,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T11:58:43.418772+00:00
8BxGGMjCEemLobs1YapPzw,b53nbDmi,https://europepmc.org/articles/PMC5502978/,collagens,ne. Cartilage matrix is rich in ," and proteoglycans, with the dom",TextQuoteSelector,TextPositionSelector,10085,10094,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:05:18.660735+00:00
6F7y3MjBEemoOE88gj_DTQ,b53nbDmi,https://europepmc.org/articles/PMC5502978/,transforming growth factor-β3,sone (all Sigma) and 10 ng·mL−1 ," (TGF-β3; GroPep, Adelaide, Aust",TextQuoteSelector,TextPositionSelector,24391,24420,WS_GP,no,WS_GP,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T11:57:56.239491+00:00
5ajFHMjCEemHlR-6c_hQfQ,b53nbDmi,https://europepmc.org/articles/PMC5502978/,collagen type I,tion through the attenuation of , synthesis; however these effect,TextQuoteSelector,TextPositionSelector,45124,45139,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:05:01.149834+00:00
4SWn_sjBEemylh8yJtO1ow,b53nbDmi,https://europepmc.org/articles/PMC5502978/,bovine,low-glucose DMEM with 10% fetal ," serum (Lonza, Waverly, Australi",TextQuoteSelector,TextPositionSelector,21833,21839,WT_OG,yes,[WT_OG][ALL],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T11:57:44.042815+00:00
3P8-WsjCEemRGg-ksP1VvA,b53nbDmi,https://europepmc.org/articles/PMC5502978/,IgG,ion) or isotype controls (mouse ,", Jackson, 1:1000) were used. Su",TextQuoteSelector,TextPositionSelector,29045,29048,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:04:46.445942+00:00
2gO-osjBEem54esk3Kamyg,b53nbDmi,https://europepmc.org/articles/PMC5502978/,defects,g of cartilage or osteochondral ,", wherein deposition of a polyme",TextQuoteSelector,TextPositionSelector,11726,11733,WT_DS,yes,[WT_DS][ALL],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T11:57:32.045930+00:00
1dV_6sjCEemSSqt1lNZ0nA,b53nbDmi,https://europepmc.org/articles/PMC5502978/,antibodies,II staining procedures. Primary , were diluted in 2% goat serum i,TextQuoteSelector,TextPositionSelector,28507,28517,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:04:34.544656+00:00
0MlS4sjCEemigYvQAgBEyA,b53nbDmi,https://europepmc.org/articles/PMC5502978/,collagen II," the cartilage, for instance in ", content: ~60% dry weight in car,TextQuoteSelector,TextPositionSelector,10757,10768,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:04:26.163271+00:00
04a_jsjBEemUKPdMgyUI0g,b53nbDmi,https://europepmc.org/articles/PMC5502978/,human, chondrogenesis in culture with ," articular chondrocytes, and ver",TextQuoteSelector,TextPositionSelector,9271,9276,CRT_OG,yes,[CRT_OG][ALL],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T11:57:21.179357+00:00
-sDpJsjBEembJ-MQXQfAWA,b53nbDmi,https://europepmc.org/articles/PMC5502978/,transforming growth factor, chondrogenic medium containing , (TGF)-β3. It has been shown tha,TextQuoteSelector,TextPositionSelector,44734,44760,WS_GP,no,WS_GP,,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T11:58:26.862185+00:00
-ltU6MjCEemUKcuZCoqmkg,b53nbDmi,https://europepmc.org/articles/PMC5502978/,collagen,"roteoglycans, with the dominant ", type (>90%) being collagen type,TextQuoteSelector,TextPositionSelector,10132,10140,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,A Hydrogel Model Incorporating 3D-Plotted Hydroxyapatite for Osteochondral Tissue Engineering.,2019-08-27T12:05:35.791467+00:00
